Allergies News and Research

Latest Allergies News and Research

Researchers find evidence that A. gambiae mosquito is evolving into two strains, could present challenges for malaria control efforts

The Anopheles gambiae mosquito, one of the major carriers of the malaria parasite in Sub-Saharan Africa, is evolving in two directions, according to two studies published Thursday in the journal Science, Scientific American's Observations blog reports.

25 Oct 2010

Research project on food allergy to showcase results at symposium in Nice

A research project on food allergy that involved 25 countries worldwide will showcase some of its results at a symposium in Nice starting today. "What we found won't make it easy to pinpoint which foods carry the biggest risk, as the risk for individual foods varies from country to country," says project coordinator Professor Clare Mills from the Institute of Food Research.

22 Oct 2010

NIH awards three new SBIR grants to Taiga

Taiga Biotechnologies, Inc. today announced that the company has received three new Small Business Innovation Research (SBIR) grants from the National Institutes of Health, totaling $1.7 million. This adds to the two previous grants awarded to Taiga for various applications of its proprietary technology platforms, for a total in NIH funding to date of over $2.1 million.

22 Oct 2010

UCLA researchers receive NIH grant to study HIV-positive men from LA County jails

A team of UCLA researchers has received a $4.6 million grant from the National Institutes of Health to study ways to get HIV-positive men who have been released from Los Angeles County jails into medical care and on sustained treatment.

22 Oct 2010

CKI to distribute Allergy Technologies' ActiveGuard mattress liners

Cadence Keen Innovations (CKI) has recently announced that it will be the exclusive distributor of Allergy Technologies' ActiveGuard Mattress Liners, which kill bed bugs within 72 hours, to the cruise industry and other CKI-supported hospitality facilities.

21 Oct 2010

Study finds black rice bran may reduce inflammation

Scientists are reporting evidence that black rice a little-known variety of the grain that is the staple food for one-third of the world population may help soothe the inflammation involved in allergies, asthma, and other diseases.

21 Oct 2010

Aqueous cream worsens eczema: Study

Researchers claim that a cream that is often used in a skin condition called eczema may actually make the condition worse. The research conducted at Bath University found that aqueous cream thinned the skin after a few weeks of use. They found that the cream contains a detergent rather than just moisturizers. The team also said that most GPs seemed unaware of official advice not to prescribe the cream as a moisturizer.

21 Oct 2010

Cipla launches generic Pirfenidone for IPF

Cipla, among the world's leading generic pharmaceutical companies, has introduced Pirfenidone in India under the brand name Pirfenex, for the treatment of IPF. A chronic progressive form of lung disease, IPF has average survival rates as low as 3-5 years which is less than many cancers. Till now there is no approved treatment for IPF.

20 Oct 2010

LANL's researcher to implement first human trial of mosaic HIV vaccine candidate

Los Alamos National Laboratory researcher Bette Korber is part of an international team of investigators working to design and implement the first human trial of a mosaic HIV vaccine candidate. The vaccine represents a novel strategy for fighting the virus that causes AIDS by attempting to address one of the most daunting challenges in HIV vaccine design: the virus's extensive genetic diversity.

20 Oct 2010

NIAID announces four new contracts for clinical trials to address problem of antimicrobial resistance

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced four new contracts for large-scale clinical trials that address the problem of antimicrobial resistance.

20 Oct 2010

Novartis announces six-year data of Reclast injection for postmenopausal women with osteoporosis

Novartis announced today that new six-year data reinforce the long-term efficacy and safety profile of once-yearly Reclast (zoledronic acid) injection in postmenopausal women with osteoporosis.The study of more than 1,200 women was presented this weekend at the annual meeting of the American Society for Bone and Mineral Research (ASBMR) in Toronto, ON, Canada.

19 Oct 2010

Chemicals in everyday substances increase risk of allergies in children

The use of chemicals in our everyday lives entails increased risks of allergies in children, according to a study at Karlstad University in Sweden. The prevalence of PGEs, propylene glycol and glycol ethers, in bedroom air is associated with asthma, hay fever, and eczema, but also with antibodies against common allergens in children. The study shows a risk increase of up to 180 percent.

19 Oct 2010

New research coalition to design first human trial of mosaic HIV vaccine candidate

Duke University Medical Center vaccine experts have assembled an international team of investigators to design and implement the first human trial of a mosaic HIV vaccine candidate, a novel strategy that attempts to counter one of the most daunting challenges in HIV vaccine design: the virus's extensive genetic diversity

19 Oct 2010

Scientists complete genetic blueprints for 13 different strains of Lyme disease bacteria

Scientists supported by the National Institutes of Health (NIH) have determined the complete genetic blueprints for 13 different strains of Borrelia burgdorferi, the bacteria that cause Lyme disease. The achievement should lead to a better understanding of how genetic variations among strains may result in different courses of illness in people with Lyme disease, the most common tickborne disease in North America. The wealth of new genetic data will also help scientists develop improved ways to diagnose, treat and prevent Lyme disease.

19 Oct 2010

Revised guidelines for first aid

The American Red Cross and American Heart Association today announced changes to guidelines for administering first aid. Among the revisions are updated recommendations for the treatment of snake bites, anaphylaxis (shock), jellyfish stings and severe bleeding. The First Aid Guidelines are being published in Circulation: Journal of the American Heart Association.

19 Oct 2010

Egg allergy is no reason to avoid 2010-2011 flu vaccination

Having an egg allergy is not a reason to avoid getting the 2010-2011 flu vaccination.

19 Oct 2010

Tylenol batch recalled due to strange smell

Johnson and Johnson’s (J&J) commonly used over-the-counter painkiller Tylenol has been recalled again in some batches because of complaints of a musty or moldy odor in the product. The company is facing a U.S. congressional probe of quality control lapses in the past as well. The drugs recalled to date include the painkiller Motrin and allergy treatment Benadryl as well as this batch of 100,000 bottles of Tylenol.

18 Oct 2010

Fluticasone gets rid of eosinophils in the esophagus, but does not improve symptoms

A group of Mayo Clinic researchers conducted the first controlled trial of swallowed fluticasone nasal spray (also known as Flonase) on people with the allergic esophageal condition called eosinophilic esophagitis. Research showed that the aerosolized swallowed allergy drug helped treat the cause of the throat condition, but symptoms lingered. The researchers' findings were presented today at the Annual Scientific Meeting of the American College of Gastroenterology in San Antonio.

18 Oct 2010

NanoViricides' President delivers speech at ASNM Second Annual Conference

NanoViricides, Inc. announced today that the Company President was invited to and presented a talk at the Second Annual Conference of the American Society for NanoMedicine (ASNM).

18 Oct 2010

Phase III study influences WHO to change guidelines for HIV-infected women receiving nevirapine

Findings from a study, which appear in the Oct. 14, 2010 New England Journal of Medicine, helped influence the World Health Organization (WHO) to change its guidelines this year for the treatment of HIV-infected women who receive a single dose of the antiretroviral drug nevirapine to prevent HIV transmission to their babies.

18 Oct 2010

Allergies News and Research

Latest Allergies News and Research

Researchers find evidence that A. gambiae mosquito is evolving into two strains, could present challenges for malaria control efforts

Research project on food allergy to showcase results at symposium in Nice

NIH awards three new SBIR grants to Taiga

UCLA researchers receive NIH grant to study HIV-positive men from LA County jails

CKI to distribute Allergy Technologies' ActiveGuard mattress liners

Study finds black rice bran may reduce inflammation

Aqueous cream worsens eczema: Study

Cipla launches generic Pirfenidone for IPF

LANL's researcher to implement first human trial of mosaic HIV vaccine candidate

NIAID announces four new contracts for clinical trials to address problem of antimicrobial resistance

Novartis announces six-year data of Reclast injection for postmenopausal women with osteoporosis

Chemicals in everyday substances increase risk of allergies in children

New research coalition to design first human trial of mosaic HIV vaccine candidate

Scientists complete genetic blueprints for 13 different strains of Lyme disease bacteria

Revised guidelines for first aid

Egg allergy is no reason to avoid 2010-2011 flu vaccination

Tylenol batch recalled due to strange smell

Fluticasone gets rid of eosinophils in the esophagus, but does not improve symptoms

NanoViricides' President delivers speech at ASNM Second Annual Conference

Phase III study influences WHO to change guidelines for HIV-infected women receiving nevirapine

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Allergies News and Research

Latest Allergies News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in